CASC11: A Drug Target / Disease Biomarker (G100270680)

Target Name: CASC11

NCBI ID: G100270680

CASC11

CASC11: A Drug Target / Disease Biomarker

CASC11 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer.

One of the main functions of CASC11 is to regulate cell-cell adhesion. This is the process by which cells stick together to form tissues and organs. In many diseases, including cancer, this process goes wrong and cells become uncontrolled and begin to divide out of control.

CASC11 plays a key role in preventing this from happening by regulating the movement of cells along the surface of the body. It does this by helping to ensure that cells stick to each other and to the surrounding tissue.

In addition to its role in cell-cell adhesion, CASC11 has also been shown to play a key role in the development and progression of a number of diseases. For example, studies have shown that CASC11 is often overexpressed in many types of cancer, including breast, lung, and ovarian cancer. This increase in the level of CASC11 has been linked to the development of a number of negative outcomes in these diseases, including the growth of tumors, the spread of cancer to other parts of the body, and the development of invasive tumors.

CASC11 is also a potential drug target for several diseases. For example, studies have shown that inhibiting the activity of CASC11 has the potential to be a effective treatment for breast cancer. This is because CASC11 is often overexpressed in breast tissue and is thought to play a role in the growth and progression of breast cancer.

In addition to its potential as a drug target, CASC11 is also a potential biomarker for several diseases. For example, studies have shown that the level of CASC11 is often elevated in the blood of people with cancer. This increase in the level of CASC11 has been linked to the development and progression of many types of cancer, including breast, lung, and ovarian cancer.

In conclusion, CASC11 is a protein that plays a key role in the regulation of cell-cell adhesion and has been implicated in a number of diseases, including cancer. It is also a potential drug target and biomarker for several diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments for CASC11-related diseases.

Protein Name: Cancer Susceptibility 11

The "CASC11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CASC11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets